Metabolic evidence for sequestration of low-density lipoprotein in abdominal aorta of normal rabbitsSCHWENKE, Dawn C.American journal of physiology. Heart and circulatory physiology. 2000, Vol 48, Num 3, pp H1128-H1140, issn 0363-6135Article

Does lack of tocopherols and tocotrienols put women at increased risk of breast cancer?SCHWENKE, Dawn C.Journal of nutritional biochemistry. 2002, Vol 13, Num 1, pp 2-20, issn 0955-2863Article

Improvement of Postprandial Endothelial Function After a Single Dose of Exenatide in Individuals With Impaired Glucose Tolerance and Recent-Onset Type 2 DiabetesKOSKA, Juraj; SCHWARTZ, Eric A; MULLIN, Michael P et al.Diabetes care. 2010, Vol 33, Num 5, pp 1028-1030, issn 0149-5992, 3 p.Article

Soy protein reduces the arterial low-density lipoprotein (LDL) concentration and delivery of LDL cholesterol to the arteries of diabetic and nondiabetic male cynomolgus monkeysWAGNER, Janice D; LI ZHANG; GREAVES, Kathryn A et al.Metabolism, clinical and experimental. 2000, Vol 49, Num 9, pp 1188-1196, issn 0026-0495Article

Determination of calcium, iron and magnesium in rabbit arteries by inductively coupled plasma atomic emission spectrometryZHENG YANG; XIANDENG HOU; JONES, Bradley T et al.Microchemical journal. 2002, Vol 72, Num 1, pp 49-54, issn 0026-265XArticle

Fiber Intake and Plasminogen Activator Inhibitor-1 in Type 2 Diabetes: Look AHEAD (Action for Health in Diabetes) Trial Findings at Baseline and Year 1BELALCAZAR, L. Maria; ANDERSON, Andrea M; TRACY, Russell P et al.Journal of the Academy of Nutrition and Dietetics (Print). 2014, Vol 114, Num 11, pp 1800-1810, issn 2212-2672, 11 p.Article

Metabolic Factors, Adipose Tissue, and Plasminogen Activator Inhibitor-1 Levels in Type 2 Diabetes Findings From the Look AHEAD StudyBELALCAZAR, L. Maria; BALLANTYNE, Christie M; WEI LANG et al.Arteriosclerosis, thrombosis, and vascular biology. 2011, Vol 31, Num 7, pp 1689-1695, issn 1079-5642, 7 p.Article

Marine ω-3 Fatty Acid Intake: Associations with cardiometabolic risk and response to weight loss intervention in the Look AHEAD (Action for Health in Diabetes) studyBELALCAZAR, L. Maria; REBOUSSIN, David M; HAFFNER, Steven M et al.Diabetes care. 2010, Vol 33, Num 1, pp 197-199, issn 0149-5992, 3 p.Article

A 1-Year Lifestyle Intervention for Weight Loss in Individuals With Type 2 Diabetes Reduces High C-Reactive Protein Levels and Identifies Metabolic Predictors of Change: From the Look AHEAD (Action for Health in Diabetes) studyBELALCAZAR, L. Maria; REBOUSSIN, David M; HAFFNER, Steven M et al.Diabetes care. 2010, Vol 33, Num 11, pp 2297-2303, issn 0149-5992, 7 p.Article

Baseline Adiponectin Levels Do Not Influence the Response to Pioglitazone in ACT NOWTRIPATHY, Devjit; CLEMENT, Stephen C; RATNER, Robert E et al.Diabetes care. 2014, Vol 37, Num 6, pp 1706-1711, issn 0149-5992, 6 p.Article

Prediction of Diabetes Based on Baseline Metabolic Characteristics in Individuals at High RiskDEFRONZO, Ralph A; TRIPATHY, Devjit; RATNER, Robert E et al.Diabetes care. 2013, Vol 36, Num 11, pp 3607-3612, issn 0149-5992, 6 p.Article

Prevention of Diabetes With Pioglitazone in ACT NOW: Physiologic CorrelatesDEFRONZO, Ralph A; TRIPATHY, Devjit; MUDALIAR, Sunder et al.Diabetes (New York, NY). 2013, Vol 62, Num 11, pp 3920-3926, issn 0012-1797, 7 p.Article

Multiple defects in counterregulation of hypoglycemia in modestly advanced type 2 diabetes mellitusISRAELIAN, Zarmen; SZOKE, Ervin; WOERLE, Juergen et al.Metabolism, clinical and experimental. 2006, Vol 55, Num 5, pp 593-598, issn 0026-0495, 6 p.Article

Plasma concentrations of trans fatty acids in persons with type 2 diabetes between September 2002 and April 2004SCHWENKE, Dawn C; FOREYT, John P; MILLER, Edgar R et al.The American journal of clinical nutrition. 2013, Vol 97, Num 4, pp 862-871, issn 0002-9165, 10 p.Article

Pioglitazone for Diabetes Prevention in Impaired Glucose ToleranceDEFRONZO, Ralph A; TRIPATHY, Devjit; MACK, Wendy J et al.The New England journal of medicine. 2011, Vol 364, Num 12, pp 1104-1115, issn 0028-4793, 12 p.Article

Intensive Glucose-Lowering Therapy Reduces Cardiovascular Disease Events in Veterans Affairs Diabetes Trial Participants With Lower Calcified Coronary AtherosclerosisREAVEN, Peter D; MORITZ, Thomas E; RAO, R. Harsha et al.Diabetes (New York, NY). 2009, Vol 58, Num 11, pp 2642-2648, issn 0012-1797, 7 p.Article

Soy protein with isoflavones, but not an isoflavone-rich supplement, improves arterial low-density lipoprotein metabolism and atherogenesisWAGNER, Janice D; SCHWENKE, Dawn C; GREAVES, Kathryn A et al.Arteriosclerosis, thrombosis, and vascular biology. 2003, Vol 23, Num 12, pp 2241-2246, issn 1079-5642, 6 p.Article

Exenatide suppresses postprandial elevations in lipids and lipoproteins in individuals with impaired glucose tolerance and recent onset type 2 diabetes mellitusSCHWARTZ, Eric A; KOSKA, Juraj; MULLIN, Michael P et al.Atherosclerosis. 2010, Vol 212, Num 1, pp 217-222, issn 0021-9150, 6 p.Article

Association between IL-6 and the extent of coronary atherosclerosis in the veterans affairs diabetes trial (VADT)SAREMI, Aramesh; ANDERSON, Robert J; PING LUO et al.Atherosclerosis. 2009, Vol 203, Num 2, pp 610-614, issn 0021-9150, 5 p.Article

Differences in LDL oxidizability by glycemic status: The Insulin Resistance Atherosclerosis StudySCHWENKE, Dawn C; D'AGOSTINO, Ralph B; GOFF, David C et al.Diabetes care. 2003, Vol 26, Num 5, pp 1449-1455, issn 0149-5992, 7 p.Article

Determinants of bioactivity of oxidized phospholipids: Specific oxidized fatty acyl groups at the sn-2 positionSUBBANAGOUNDER, Ganesamoorthy; LEITINGER, Norbert; SCHWENKE, Dawn C et al.Arteriosclerosis, thrombosis, and vascular biology. 2000, Vol 20, Num 10, pp 2248-2254, issn 1079-5642Article